# Seer to Participate in the TD Cowen 46th Annual Health Care Conference
Canonical URL: https://biopharmsignal.com/news/SEER/seer-to-participate-in-the-td-cowen-46th-annual-health-care-conference
Ticker: SEER
Company: Seer, Inc
Source: Seer, Inc
Published: 2026-02-18 21:05 EST
Original Source URL: https://investor.seer.bio
## Summary

REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming TD Cowen 46 th Annual Health Care Conference in Boston, MA.

## Article Body
REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming TD Cowen 46 th Annual Health Care Conference in Boston, MA.
## Recent Company News
- 2026-07-20 11:00 EST — [Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY](https://biopharmsignal.com/news/SEER/seer-urges-stockholders-to-vote-for-seer-s-highly-qualified-director-nominees-on-6787833a) — Source: Seer, Inc
- 2026-07-20 10:00 EST — [Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.](https://biopharmsignal.com/news/SEER/special-committee-of-seer-s-board-of-directors-unanimously-rejects-unsolicited-a-61f31e25) — Source: Seer, Inc
- 2026-07-14 20:05 EST — [Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight](https://biopharmsignal.com/news/SEER/seer-board-of-directors-issues-letter-to-shareholders-setting-the-record-straigh-cbf9fae4) — Source: Seer, Inc
- 2026-07-08 11:00 EST — [Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees](https://biopharmsignal.com/news/SEER/seer-board-of-directors-issues-letter-to-shareholders-demonstrating-the-strength-2fe1284b) — Source: Seer, Inc
- 2026-07-06 11:00 EST — [Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential](https://biopharmsignal.com/news/SEER/seer-files-investor-presentation-highlighting-strong-momentum-commercial-opportu-e67fff29) — Source: Seer, Inc
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)